0      0

JL1123ES - JL1123ES: Myelosuppression and healthcare utilization among chemotherapy treated extensive-stage small cell lung cancer (ES-SCLC) patients with and without trilaciclib from community oncology practices

‐ Oct 24, 2023 4:00pm

Full author listing

Ajeet Gajra, MD, MBBS, FACP (1),(2), Peter Reeves, PhD (3), Susan O’Brien, MS (4), Victor Giancarlo Sal y Rosas Celi, PhD (5), Michelle Moore, RPH (6), Huan Huang, PhD (6)

Affiliations: 1) Hematology-Oncology Associates of CNY, Syracuse, NY, United States; 2) National Cancer Care Alliance, United States; 3) Sumaq Life LLC, East Lansing, MI, United States; 4) Electronic Medical Office Logistics (EMOL Health) LLC, Royal Oak, MI, United States; 5) Pontificia Universidad Católica del Perú, Lima, Perú; 6) G1 Therapeutics, Research Triangle Park, NC, United States


You must be logged in and own this session in order to post comments.